Tinea capitis requires systemic treatment because antifungal
creams are unable to penetrate the hair shaft sufficiently to clear the
infection. Furthermore, the use of topical antifungal treatment alone may
contribute to the creation of carriers. The concept of carriers is
controversial but describes patients whose symptoms and clinical sings are
mammal but who are still mycologically
positive and presumed capable of transmitting infection.
The only licensed
treatment is oral griseofulvin. It is usually given at a dose of 10mg/kg for
six to eight weeks. However, T. tonsurans seems resistant in some cases, and longer
treatment may be required at doses of up to 20- 25mg/kg. Because treatment
takes a long time. Higgins et al
(2000)
REFERENCES
Ogbonna, C.I.C,
Robinson, R.O, Abubakar, J.M . (1985).The distribution of ringworm
infections among primary school children in jos, plateau state of Nigeria.
Mycopathologia 89, 101- 106.
Omar, A. A. (2000).
Ringworm of the scalp in primary school children in Alenandria: infection and
carriage. Eastern Mediteranean Health Journal. 6(5): 961- 967.
Rippon, J. W.
(1974). Medical Mycology: The pathogenic fungi and pathogenic Actinomycetes.
W.B. sunders, C.phsadephia London Toronto, 74pp.
Temple M.E, Staats
C.C Korstanje M.J. (1999).
Fungal infection in the Netherlands
prevailing fungi and pattern infection dematol. 190: 39 -42
Venugopal, P.V,
Venugopal, T.V. (1993). Tinea capitis in sandi Arania, int. journal
Dermatologist. 32: 39 – 40.
Weary,P.E. (1968)
Pityrosporum ovale. Observations on some aspects of host- parasite
interrelationship. Archs. Desm. 98, 408.